Affiliations 

  • 1 Division of Cardiology, Ulsan Medical Center, Ulsan Hospital, Ulsan, South Korea. sesim1989@gmail.com
  • 2 Cardiology Department and Clinical Research Center, Queen Elizabeth Hospital II, Kota, Kinabalu, Malaysia
  • 3 Division of Cardiology, Ulsan Medical Center, Ulsan Hospital, Ulsan, South Korea
  • 4 Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea
  • 5 East Lancashire Hospitals NHS Trust, Blackburn, Lancashire, United Kingdom
  • 6 Department of Internal Medicine and Cardiovascular Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
  • 7 Division of Cardiology, Inje University Ilsan Paik Hospital, Goyang, South Korea
  • 8 Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
  • 9 Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea
  • 10 Division of Cardiology, Department of Internal Medicine, Beijing University Shougang Hospital, Beijing, China
Cardiol J, 2021;28(4):615-622.
PMID: 32789835 DOI: 10.5603/CJ.a2020.0105

Abstract

Although drug-eluting stents (DES) have become the mainstay of percutaneous coronary intervention, late and very late stent thrombosis remains a concern. Drug-coated balloons (DCB) have the advantage of preserving the anti-restenotic benefits of DES while minimizing potential long-term safety concerns. Currently the two methods to ensure successful DCB treatment of a stenotic lesion are angiography or physiology-guided DCB application. This review will evaluate these two methods based on previous evidence and make suggestions on how to perform DCB treatment more efficiently and safely.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.